ON-Demand VideosAdvancing Anticoagulation for Atrial Fibrillation Patients “Lixiana Launch” (18th of December 2020)

https://ecsociety.com/wp-content/uploads/2018/08/ecs_logo_full.png

https://ecsociety.com/wp-content/uploads/2018/08/ema_logo.png

https://ecsociety.com/wp-content/uploads/2018/08/ecs_logo_full.png

Advancing Anticoagulation for Atrial Fibrillation Patients “Lixiana Launch”

Date: 18 December

Time: 19:00-20:30 UAE Time

Chairman: Dr. Wael Almahmeed

Speakers: Dr. Christian T. Ruff /Dr. Hani Sabbour

Supported by

https://ecsociety.com/wp-content/uploads/2020/12/Lixiana.png

https://ecsociety.com/wp-content/uploads/2020/12/saja.jpg

Program
Preview

19:00-19:05

Introduction

Wael Almahmeed, UAE
19:05-19:25

A new Era in Anticoagulation for AF

Hani Sabbour, UAE
19:25-20:05

Insights from the ENGAGE AF-TIMI 48 Trial: The Efficacy and Safety of Edoxaban in High-Risk Patients

Christian T. Ruff, USA
20:05-20:25

Panel Discussion
20:25-20:30

Take Home Message

Wael Almahmeed, UAE